Hubei Soundny Biotechnology Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
88
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3.17M
- Investors
-
4
Hubei Soundny Biotechnology General Information
Description
Developer of a drug-loaded vesicle treatment intended to treat tumor. The company's treatment basically focuses on the tumor cells with chemotherapeutic drugs, enabling patients to get proper cure in an enhanced manner.
Contact Information
Website
www.soundnybio.comCorporate Office
- 13th Floor, Block C
- New World Center, 634 Jiefang Avenue
- Wuhan, Hubei
- China
Corporate Office
- 13th Floor, Block C
- New World Center, 634 Jiefang Avenue
- Wuhan, Hubei
- China
Hubei Soundny Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 14-Dec-2018 | $3.17M | Completed | Generating Revenue | ||
| 4. Later Stage VC | 31-Jul-2017 | Completed | Generating Revenue | |||
| 3. IPO | 06-Feb-2017 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 09-Mar-2016 | $3.42M | $4.23M | Completed | Generating Revenue | |
| 1. Later Stage VC | 15-Aug-2014 | $809K | $809K | Completed | Generating Revenue |
Hubei Soundny Biotechnology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 27,380,000 | $0.14 | $0.14 | 1x | $0.14 | 28.52% |
Hubei Soundny Biotechnology Patents
Hubei Soundny Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018145588-A1 | Use of cell vesicle formulation combined with low dose radiotherapy in preparation of antitumor drugs | Inactive | 09-Feb-2017 | ||
| WO-2018130108-A1 | Oral tumor vaccine and use thereof | Inactive | 12-Jan-2017 | ||
| US-20190224238-A1 | Tumor therapeutic drug | Inactive | 05-Sep-2016 | ||
| WO-2018041261-A1 | Tumor therapeutic drug | Inactive | 05-Sep-2016 | ||
| EP-3305310-A1 | Oncolytic virus formulation and preparation method thereof | Active | 29-May-2015 | A61K9/5068 |
Hubei Soundny Biotechnology Signals
Hubei Soundny Biotechnology Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| China Science & Merchants Investment Management Group | PE/Buyout | Minority | ||
| Wuhan Institute of Biotechnology | Government | Minority | ||
| Wuhan Optics Valley Elite Investment Management | Venture Capital | Minority | ||
| Huasheng Yihong | Venture Capital | Minority |
Hubei Soundny Biotechnology FAQs
-
When was Hubei Soundny Biotechnology founded?
Hubei Soundny Biotechnology was founded in 2009.
-
Where is Hubei Soundny Biotechnology headquartered?
Hubei Soundny Biotechnology is headquartered in Wuhan, China.
-
What is the size of Hubei Soundny Biotechnology?
Hubei Soundny Biotechnology has 88 total employees.
-
What industry is Hubei Soundny Biotechnology in?
Hubei Soundny Biotechnology’s primary industry is Drug Delivery.
-
Is Hubei Soundny Biotechnology a private or public company?
Hubei Soundny Biotechnology is a Private company.
-
What is the current valuation of Hubei Soundny Biotechnology?
The current valuation of Hubei Soundny Biotechnology is .
-
What is Hubei Soundny Biotechnology’s current revenue?
The current revenue for Hubei Soundny Biotechnology is .
-
How much funding has Hubei Soundny Biotechnology raised over time?
Hubei Soundny Biotechnology has raised $18.8M.
-
Who are Hubei Soundny Biotechnology’s investors?
China Science & Merchants Investment Management Group, Wuhan Institute of Biotechnology, Wuhan Optics Valley Elite Investment Management, and Huasheng Yihong have invested in Hubei Soundny Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process